Picture of Rhythm Pharmaceuticals logo

RYTM — Rhythm Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Rhythm Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

* Rhythm Pharmaceuticals Inc  RYTM.OQ  reported a quarterly
adjusted loss of $2.35​​ per share for the quarter ended in
March, lower than the same quarter last year, when the company
reported EPS of -92 cents.  The mean expectation of
nine analysts for the quarter was for a loss of $2.16 per share.
Wall Street expected results to range from $-2.41 to -61 cents
per share.
    * Revenue rose 126.4% to $25.97 million from a year ago;
analysts
expected $26.90 million. 
    * Rhythm Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $2.35​.
    * The company reported a quarterly loss of $141.37 million.
    * Rhythm Pharmaceuticals Inc shares had risen by 1.3% this
quarter and lost 4.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 207.1% in the last three months.​ 
    * In the last 30 days, three analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Rhythm
Pharmaceuticals Inc is $55.00 
This summary was machine generated from LSEG data May 7 at 05:46
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -2.16          -2.35          Missed
 Dec. 31 2023      -0.70          -0.70          Met
 Sep. 30 2023      -0.74          -0.76          Missed
 Jun. 30 2023      -0.79          -0.82          Missed

Recent news on Rhythm Pharmaceuticals

See all news